You are here

Europe

Bayer secures approval in the EU for Xarelto® (rivaroxaban) for patients with coronary or peripheral artery disease

Bayer secures approval in the EU for Xarelto® (rivaroxaban) for patients with coronary or peripheral artery disease

Pipeline Review

Flag link:

European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade

European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade

CP WIre

hepatocellular carcinoma

Flag link:

Jazz hiring 100-plus sales representatives to prep for new narcolepsy and AML launches

Jazz hiring 100-plus sales representatives to prep for new narcolepsy and AML launches

Fierce Pharma

Jazz Pharmaceuticals

Flag link:

Bayer targets COPD in a new discovery alliance with Haplogen, Evotec

Bayer targets COPD in a new discovery alliance with Haplogen, Evotec

Endpoints

Flag link:

Better U.S. Patient Access To Cancer Drugs Comes At A Price

Better U.S. Patient Access To Cancer Drugs Comes At A Price

Forbes

Flag link:

Roche gets some regulatory love for its breakthrough quest on a PhIII Huntington’s drug

Roche gets some regulatory love for its breakthrough quest on a PhIII Huntington’s drug

Endpoints

Huntington's disease

Flag link:

Brexit forces EMA to suspend tasks as job loss forecast jumps

Brexit forces EMA to suspend tasks as job loss forecast jumps

Fierce Biotech

Flag link:

Sanofi has been stockpiling drugs for no-deal Brexit: WSJ

Sanofi has been stockpiling drugs for no-deal Brexit: WSJ

Yahoo/Reuters

Flag link:

Pfizer Receives European Approval for Herceptin Biosimilar, Trazimera

Pfizer Receives European Approval for Herceptin Biosimilar, Trazimera

CP Wire

Flag link:

Opdivo Approved in Europe for Additional Use in Melanoma Patients

Opdivo Approved in Europe for Additional Use in Melanoma Patients

CP Wire

Bristol-Myers Squibb

advanced melanoma

Flag link:

AstraZeneca offloads Atacand in Europe for $200M

AstraZeneca offloads Atacand in Europe for $200M

Biopharma Dive

Flag link:

Astellas exploring selling Europe assets for $500m

Astellas exploring selling Europe assets for $500m

GoinPharma

Flag link:

AstraZeneca to stockpile drugs as Brexit 'safety net'

AstraZeneca to stockpile drugs as Brexit 'safety net'

Reuters

Flag link:

Genmab puts down $54M for immunotherapy collaboration — ready to spend millions more

Genmab puts down $54M for immunotherapy collaboration — ready to spend millions more

Endpoints

cancer immunotherapy

Flag link:

Boehringer Ingelheim Invests More Than $230 Million in Veterinary Public Health Production Center in Europe's “Vaccine Valley”

Boehringer Ingelheim Invests More Than $230 Million in Veterinary Public Health Production Center in Europe's “Vaccine Valley”

CP Wire

Boehringer Ingelheim

Flag link:

European biotech on course for record year with $3.9B raised in first half of 2018

European biotech on course for record year with $3.9B raised in first half of 2018

BioWorld

Flag link:

Sanofi, Advent finally shake hands on $2.2B European generics sale

Sanofi, Advent finally shake hands on $2.2B European generics sale

Fierce Pharma

Advent International

Flag link:

CHMP reverses course on neratinib, handing Puma an unexpected win on European marketing vote — shares soar

CHMP reverses course on neratinib, handing Puma an unexpected win on European marketing vote — shares soar

Endpoints

Puma Biotechnology

Flag link:

Comparing vaccine incentives in the US and Europe

Comparing vaccine incentives in the US and Europe

Biopharma Dive

drug development

Flag link:

What to Expect for AstraZeneca in Fiscal 2018

What to Expect for AstraZeneca in Fiscal 2018

Market Realist

Flag link:

Pages